EPS
Earnings per share, a key profitability metric.
Latest EPS: $0.39 (2026Q1); -45.8% YoY; -3.3% CAGR since 2013Q1 (13y).
Chart and table show the latest 24 of 53 quarters.
Revenue
EPS
Free Cash Flow
Gross Margin
FCF Margin
P/E Ratio
Cumulative FCF
Shares Outstanding
Rule of 40
Quarterly EPS Data
Chart and table show the latest 24 of 53 quarters.
| Period | Value |
|---|---|
| 2020Q2 | -$0.46 |
| 2020Q3 | $1.29 |
| 2020Q4 | -$0.13 |
| 2021Q1 | $1.99 |
| 2021Q2 | $0.42 |
| 2021Q3 | $1.78 |
| 2021Q4 | $2.26 |
| 2022Q1 | $2.51 |
| 2022Q2 | $0.51 |
| 2022Q3 | $2.21 |
| 2022Q4 | $1.40 |
| 2023Q1 | $0.13 |
| 2023Q2 | $1.14 |
| 2023Q3 | $1.00 |
| 2023Q4 | $0.45 |
| 2024Q1 | $0.77 |
| 2024Q2 | $0.77 |
| 2024Q3 | $0.88 |
| 2024Q4 | -$0.03 |
| 2025Q1 | $0.72 |
| 2025Q2 | $0.52 |
| 2025Q3 | $0.10 |
| 2025Q4 | $1.02 |
| 2026Q1 | $0.39 |
Healthcare Comparison
1 / 3
Other ABBV Charts
More quarter-by-quarter fundamentals for AbbVie Inc.
1 / 8